(2)
Jan. 27, 2021
Philips Abdominal Aortic Aneurysm (AAA) Model helps increase diagnostic confidence and improved patient experience compared to current standard of care
Amsterdam, the Netherlands -
Royal Philips, providing physicians a more patient-friendly solution compared to the current standard of care for managing AAA patients. Based on 3D ultrasound, Philips AAA Model delivers clinicians accurate diagnostic information without exposing patients to high doses of radiation and nephrotoxic contrast agents.
An abdominal aortic aneurysm (AAA) is an aneurysm that forms in the lower part of the aorta. Typically, AAAs are identified incidentally during abdominal imaging exams but, in some cases, remain undetected until rupture. A ruptured AAA has an 80% mortality rate [1], emphasizing the importance of routine surveillance. Philips AAA Model integrates innovative software and leading Philips 3D ultrasound technologies into a single solution to help increase diagnostic confidence
Philips integrates 3D ultrasound with innovative software for breakthrough in surveillance of abdominal aortic aneurysms
January 27, 2021 04:00 ET | Source: Royal Philips Royal Philips
Jan. 27, 2021
Philips Abdominal Aortic Aneurysm (AAA) Model helps increase diagnostic confidence and improved patient experience compared to current standard of care
Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has introduced the
Philips Abdominal Aortic Aneurysm (AAA) Model, providing physicians a more patient-friendly solution compared to the current standard of care for managing AAA patients. Based on 3D ultrasound, Philips AAA Model delivers clinicians accurate diagnostic information without exposing patients to high doses of radiation and nephrotoxic contrast agents.
(2)
January 25, 2021
Hospital will have access to Philips latest technologies and informatics solutions to enhance the diagnosis, treatment, monitoring and management of patients
Multi-year strategic partnership will accelerate clinical research focused on image-guided minimally-invasive therapy, neurology, intensive care units and digital pathology
Amsterdam, the Netherlands -
Royal Philips, one of France s leading hospitals in image-guided interventions, robotics and clinical research, today announced the signing of a 5-year technology and innovation partnership to support diagnostic, interventional imaging and patient monitoring and management, undertake clinical research, and leverage Philips and Rennes University Hospital s ecosystems of open innovation to foster French start-up companies.
Philips will deliver new medical technologies and provide management and maintenance services for the hospital s diagnostic and interventional imaging modalities (MRI, CT, and image-gu
January 25, 2021 Fourth-quarter highlights• Sales amounted to EUR 6.0 billion, with 7% comparable sales growth• Comparable order intake increased 7%• Income from continuing operations
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ .
Royal PhilipsJanuary 25, 2021 GMT
January 25, 2021
5-year alliance will provide Vithas Group with state-of-the-art diagnostic imaging, image viewing solutions, and minimally-invasive intervention technology to deliver faster and more accurate diagnosis and treatment to patients
Vithas will become a ‘reference technology partner’ for Philips in Spain, giving it fast access to advances and innovations that Philips develops prior to their commercialization
New enterprise-wide network for diagnostic imaging will support unified working between more than 100 radiologists to facilitate workflow efficiency and research, as well as allowing patients to securely view their diagnostic reports and images on PCs and mobile devices